Robert Califf’s nomination to become the next commissioner of the U.S. Food and Drug Administration (FDA) has won an easy vote in a Senate committee – but may still face a roadblock that could delay the final approval of his appointment.
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields
Notifications